Q3 2024 Earnings Call Transcript November 18, 2024 Cellectar Biosciences, Inc. misses on earnings expectations. Reported EPS ...
AT THE MOMENT, the only FDA-approved stem cell treatment is a bone marrow transplant to treat blood diseases. The FDA has ...
Amid snowfall in parts of the country, politicians are continuing to seek votes and parties are unveiling more election ...